Shu Zhang
Guangzhou University of Chinese Medicine(CN)Capital Medical University(CN)Fudan University(CN)Beijing Chao-Yang Hospital, Capital Medical University(CN)Beijing Tian Tan Hospital(CN)First Affiliated Hospital of Guangzhou University of Chinese Medicine(CN)Huashan Hospital(CN)
Publications by Year
Research Areas
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Medical Imaging and Pathology Studies, Gastric Cancer Management and Outcomes, Chronic Obstructive Pulmonary Disease (COPD) Research, Pulmonary Hypertension Research and Treatments
Most-Cited Works
- → Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage Production(2016)257 cited
- → MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program(2021)219 cited
- → IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages(2020)143 cited
- → The methyl-CpG-binding domain 2 facilitates pulmonary fibrosis by orchestrating fibroblast to myofibroblast differentiation(2022)80 cited
- → Assessing the safety and efficacy of full robotic gastrectomy with intracorporeal robot-sewn anastomosis for gastric cancer: A randomized clinical trial(2016)67 cited
- → Incidence and radiologic‐pathological features of lung cancer in idiopathic pulmonary fibrosis(2017)35 cited